Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Gibson

Showing results (741-750 of 1,147) with videos related to

Pageof 115
Sort By:
Thorax|October 13, 2017
Timing of onset of symptoms in people with idiopathic pulmonary fibrosisThomas Hewson, Tricia M McKeever, Jack E Gibson, et al.
Health (London, England : 1997)|March 5, 2013
Becoming men: Gender, disability, and transitioning to adulthoodBarbara E Gibson, Bhavnita Mistry, Brett Smith, et al.
Journal of Cutaneous Pathology|May 4, 2013
Atypical generalized eruptive histiocytosis clonally related to chronic myelomonocytic leukemia with loss of Y chromosomeWonwoo Shon, Margot S Peters, Kurtis B Reed, et al.
IEEE Journal of Biomedical and Health Informatics|September 18, 2013
A novel semisupervised algorithm for rare prescription side effect discoveryJenna M Reps, Jonathan M Garibaldi, Uwe Aickelin, et al.
Drug Safety|February 20, 2014
Signalling paediatric side effects using an ensemble of simple study designsJenna M Reps, Jonathan M Garibaldi, Uwe Aickelin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1980
Radioiodinated estrogen derivativesJ K Mazaitis, R E Gibson, T Komai, et al.
Health (London, England : 1997)|March 25, 2025
Differences as potentials: A posthuman re-envisioning of disability and mobilityBarbara E Gibson, Carla Rice, Brenda M Gladstone, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1985
Use of 3-quinuclidinyl 4-iodobenzilate as a receptor binding radiotracerW C Eckelman, R Eng, W J Rzeszotarski, et al.
Human Pathology|May 16, 2008
Phospho-STAT5 expression pattern with the MPL W515L mutation is similar to that seen in chronic myeloproliferative disorders with JAK2 V617FSarah E Gibson, Andrew E Schade, Hadrian Szpurka, et al.
International Journal of Dermatology|June 22, 2013
Pharmacogenetics in dermatology: a patient-centered updateNneka I Comfere, Ogechi N Ikediobi, Margot S Peters, et al.
Pageof 115

Showing results (741-750 of 1,147) with videos related to

Sort By:
Pageof 115
Thorax|October 13, 2017
Timing of onset of symptoms in people with idiopathic pulmonary fibrosisThomas Hewson, Tricia M McKeever, Jack E Gibson, et al.
Health (London, England : 1997)|March 5, 2013
Becoming men: Gender, disability, and transitioning to adulthoodBarbara E Gibson, Bhavnita Mistry, Brett Smith, et al.
Journal of Cutaneous Pathology|May 4, 2013
Atypical generalized eruptive histiocytosis clonally related to chronic myelomonocytic leukemia with loss of Y chromosomeWonwoo Shon, Margot S Peters, Kurtis B Reed, et al.
IEEE Journal of Biomedical and Health Informatics|September 18, 2013
A novel semisupervised algorithm for rare prescription side effect discoveryJenna M Reps, Jonathan M Garibaldi, Uwe Aickelin, et al.
Drug Safety|February 20, 2014
Signalling paediatric side effects using an ensemble of simple study designsJenna M Reps, Jonathan M Garibaldi, Uwe Aickelin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1980
Radioiodinated estrogen derivativesJ K Mazaitis, R E Gibson, T Komai, et al.
Health (London, England : 1997)|March 25, 2025
Differences as potentials: A posthuman re-envisioning of disability and mobilityBarbara E Gibson, Carla Rice, Brenda M Gladstone, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1985
Use of 3-quinuclidinyl 4-iodobenzilate as a receptor binding radiotracerW C Eckelman, R Eng, W J Rzeszotarski, et al.
Human Pathology|May 16, 2008
Phospho-STAT5 expression pattern with the MPL W515L mutation is similar to that seen in chronic myeloproliferative disorders with JAK2 V617FSarah E Gibson, Andrew E Schade, Hadrian Szpurka, et al.
International Journal of Dermatology|June 22, 2013
Pharmacogenetics in dermatology: a patient-centered updateNneka I Comfere, Ogechi N Ikediobi, Margot S Peters, et al.
Pageof 115